title: Use of complementary and alternative medicine in children with type 1 diabetes mellitus - prevalence, patterns of use, and costs.
abstract: BACKGROUND
  Complementary and alternative medicine (CAM) is increasingly used in adults and children. Studies on CAM in diabetes have mainly focused on the adult population and its use among children with type 1 diabetes has not been well characterized.
  
  
  OBJECTIVE
  This study determines prevalence, parental reasons and motivations, perceived effectiveness, costs, and communication of CAM use. Moreover, caregiver-related variables associated with the use of CAM were investigated.
  
  
  METHODS
  A self-completed anonymous questionnaire was administered to parents of children with type 1 diabetes in four pediatric diabetes centers in Germany (Leipzig, Berlin, Stuttgart, and Bonn).
  
  
  RESULTS
  Two hundred and twenty eight (65.9%) of 346 families completed the survey. Mean age of the diabetic patients was 11.9 +/- 3.8 yr. Forty two (18.4%) received one or more types of CAM, with the most common types being homeopathy (14.5%), vitamins and minerals (13.7%), modified diet (12.9%), aloe vera (7.3%), and cinnamon (5.6%). Users had a significantly higher family income and parental tertiary education (p < 0.05) and stated a significantly stronger interest in self-care (p < 0.01). Parents' motivations for using CAM were the hope for an improved well-being (92.1%), to try everything (77.8%), and assumption of fewer side effects (55.2%). Costs for the entire treatment varied between less than euro100 and up to euro5000, with mostly no reimbursement.
  
  
  CONCLUSIONS
  Use of CAM in children with type 1 diabetes is less common than that documented for adults. Parents using CAM do not question the need for insulin. When using CAM, improved well-being and quality of life are important considerations where CAM can have a role.
authors.affiliation: Hospital for Children and Adolescents, University of Leipzig, Leipzig, Germany.
authors.forename: Karen
authors.initials: K
authors.lastname: Dannemann
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Hecker
authors.forename: Holger
authors.initials: H
authors.lastname: Haberland
authors.forename: Antje
authors.initials: A
authors.lastname: Herbst
authors.forename: Angela
authors.initials: A
authors.lastname: Galler
authors.forename: Thorsten
authors.initials: T
authors.lastname: Schäfer
authors.forename: Elmar
authors.initials: E
authors.lastname: Brähler
authors.forename: Wieland
authors.initials: W
authors.lastname: Kiess
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Kapellen
mesh_terms: D000293:Adolescent; D000328:Adult; D017668:Age of Onset; D002648:Child; D000529:Complementary Therapies / Q000191:economics* / Q000706:statistics & numerical data*; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy / Q000191:economics / Q000628:therapy*; D004282:Documentation; D005260:Female; D005858:Germany; D006306:Health Surveys; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D008297:Male; D010290:Parents; D011795:Surveys and Questionnaires
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin